Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
3.36
Dollar change
+0.09
Percentage change
2.75
%
Index- P/E- EPS (ttm)-0.94 Insider Own2.61% Shs Outstand83.94M Perf Week-4.82%
Market Cap282.04M Forward P/E- EPS next Y-0.80 Insider Trans4.78% Shs Float81.75M Perf Month3.38%
Income-63.82M PEG- EPS next Q-0.23 Inst Own63.01% Short Float2.59% Perf Quarter77.78%
Sales0.23M P/S1226.28 EPS this Y2.79% Inst Trans11.10% Short Ratio2.35 Perf Half Y69.70%
Book/sh0.86 P/B3.90 EPS next Y12.04% ROA-58.90% Short Interest2.11M Perf Year170.97%
Cash/sh0.79 P/C4.27 EPS next 5Y13.00% ROE-77.96% 52W Range1.14 - 3.80 Perf YTD138.30%
Dividend Est.- P/FCF- EPS past 5Y43.36% ROI-82.15% 52W High-11.58% Beta1.10
Dividend TTM- Quick Ratio5.41 Sales past 5Y436.18% Gross Margin-728.94% 52W Low194.74% ATR (14)0.24
Dividend Ex-Date- Current Ratio5.41 EPS Y/Y TTM2.74% Oper. Margin-28958.72% RSI (14)57.54 Volatility6.91% 7.86%
Employees59 Debt/Eq0.21 Sales Y/Y TTM-97.81% Profit Margin-27155.74% Recom1.00 Target Price20.00
Option/ShortYes / Yes LT Debt/Eq0.19 EPS Q/Q-16.23% Payout- Rel Volume0.98 Prev Close3.27
Sales Surprise-100.00% EPS Surprise-4.55% Sales Q/Q-100.00% EarningsNov 07 AMC Avg Volume898.56K Price3.36
SMA203.60% SMA5016.64% SMA20062.82% Trades Volume876,181 Change2.75%
Date Action Analyst Rating Change Price Target Change
Oct-04-24Initiated Wells Fargo Overweight $17
Sep-05-24Initiated Jefferies Buy $9
Jul-05-23Downgrade Oppenheimer Outperform → Perform
Oct-12-21Initiated RBC Capital Mkts Outperform $22
Sep-21-21Initiated Piper Sandler Overweight $19
May-10-21Initiated Laidlaw Buy $18
Aug-17-20Upgrade H.C. Wainwright Neutral → Buy $13
Mar-04-20Initiated ROTH Capital Buy $15
Mar-02-20Initiated Oppenheimer Outperform $8
Feb-14-18Downgrade JP Morgan Neutral → Underweight
Nov-15-24 08:00AM
Nov-07-24 04:01PM
Oct-31-24 08:00AM
Oct-14-24 08:00AM
Oct-08-24 08:00AM
08:00AM Loading…
Oct-02-24 08:00AM
Aug-21-24 08:00AM
Aug-13-24 04:00PM
Aug-06-24 08:00AM
Jul-30-24 08:00AM
Jul-22-24 08:00AM
Jun-18-24 09:40AM
Jun-10-24 10:52AM
Jun-05-24 03:17PM
Jun-03-24 08:00AM
04:00PM Loading…
May-24-24 04:00PM
May-15-24 07:00AM
May-14-24 08:00AM
May-06-24 08:00AM
May-02-24 09:58PM
04:15PM
04:00PM
Apr-01-24 08:00AM
Mar-26-24 02:19PM
Mar-15-24 01:33PM
11:30AM
11:01AM
Mar-14-24 08:56PM
04:16PM
04:00PM
08:00AM Loading…
Feb-28-24 08:00AM
Feb-21-24 08:00AM
Jan-29-24 08:00AM
Jan-18-24 08:00AM
Nov-13-23 08:00AM
Nov-09-23 04:07PM
04:00PM
Nov-01-23 08:00AM
Oct-31-23 08:00AM
Sep-11-23 08:00AM
Aug-30-23 09:35AM
Aug-24-23 08:00AM
Aug-09-23 05:30PM
04:29PM
04:00PM
Jul-20-23 07:30AM
Jun-28-23 07:00AM
Jun-22-23 08:00AM
Jun-20-23 08:00AM
Jun-09-23 04:00PM
Jun-06-23 08:00AM
May-25-23 08:00AM
May-22-23 08:00AM
07:33AM
May-13-23 08:06AM
May-11-23 04:00PM
May-10-23 06:11AM
May-09-23 05:15PM
04:12PM
04:00PM
May-07-23 04:00AM
May-05-23 02:24PM
Apr-17-23 08:00AM
Mar-30-23 08:00AM
Mar-28-23 10:45AM
Mar-23-23 07:10AM
Mar-21-23 08:00AM
Mar-20-23 08:00AM
Mar-09-23 05:15PM
04:00PM
Mar-08-23 08:00AM
Mar-02-23 08:00AM
Mar-01-23 08:00AM
Feb-17-23 12:00PM
Feb-10-23 05:21AM
Feb-09-23 08:00AM
Feb-08-23 04:11PM
Feb-06-23 08:00AM
Jan-31-23 08:00AM
Jan-19-23 08:00AM
Jan-18-23 08:00AM
Dec-29-22 06:59PM
Dec-15-22 08:00AM
Nov-18-22 04:00PM
Nov-10-22 05:15PM
04:00PM
08:00AM
Nov-09-22 08:00AM
Nov-03-22 08:02AM
Oct-25-22 08:00AM
Oct-11-22 08:00AM
Oct-04-22 08:00AM
Sep-29-22 08:00AM
Sep-27-22 08:00AM
Sep-16-22 08:35AM
Sep-13-22 08:00AM
Sep-12-22 08:35AM
Sep-09-22 11:52AM
08:00AM
Sep-06-22 08:00AM
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHIMMEL PAULDirectorJul 24 '24Buy1.9352,300101,038413,023Jul 24 05:29 PM
SCHIMMEL PAULDirectorJul 22 '24Buy1.7441,05271,500354,075Jul 24 05:29 PM
SCHIMMEL PAULDirectorJul 23 '24Buy1.826,64812,075360,723Jul 24 05:29 PM
DENYES NANCYGeneral CounselJun 05 '24Buy1.865,0009,27622,267Jun 06 08:26 AM
COUGHLIN TIMOTHYDirectorMay 30 '24Buy1.7550,00087,50056,000Jun 03 04:21 PM
Broadfoot Jill MarieChief Financial OfficerMay 31 '24Buy1.795,0008,95027,960Jun 03 08:38 AM
Shukla SanjayPresident and CEOMay 31 '24Buy1.8120,00036,140136,548Jun 03 08:34 AM
Broadfoot Jill MarieChief Financial OfficerFeb 06 '24Sale1.691,5902,68720,821Feb 06 08:18 PM
Shukla SanjayPresident and CEODec 12 '23Buy1.1812,00014,136106,173Dec 12 06:50 PM
Shukla SanjayPresident and CEODec 11 '23Buy1.173,0003,51094,173Dec 12 06:50 PM